DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Daranide (Dichlorphenamide) - Summary

 

-- advertisement --

DARANIDE SUMMARY

DARANIDE (Dichlorphenamide) is an oral carbonic anhydrase inhibitor.

For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.

DARANIDE NEWS HIGHLIGHTS

Published Studies Related to Daranide (Dichlorphenamide)

Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis. [2000.01]

more>>

Clinical Trials Related to Daranide (Dichlorphenamide)

Hyper- and Hypokalemic Periodic Paralysis Study [Recruiting]

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders [Completed]

more>>

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008